TerminatedNot Applicable

Pain Reduction and Ovarian Perfusion Following Uterine Fibroid Embolization

Stopped: Insufficient Enrollment

United States3 participantsStarted 2023-02-09

Plain-language summary

The goal of this study is to assess of Pressure-Enabled Drug Delivery on fibroid treatment in patients undergoing UFE.

Age range18 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Pain Reduction

Timeframe: 6 months

NCT IDNCT06106633

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01-15